NFKB1 and obesity disorder: It has also been demonstrated to bind to PPARγ and reduce obesity-associated inflammation [95], as well as reduce pro-inflammatory cytokine production by inhibiting NF-κB and TNF-α activation in a carrageenan-induced inflammation murine model [96].